Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amarin Corp Plc\Uk (AMRN) Research & Development (2016 - 2025)

Amarin Corp Plc\Uk (AMRN) has disclosed Research & Development for 13 consecutive years, with $5.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Research & Development rose 253.76% to $5.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $19.8 million, a 139.32% increase, with the full-year FY2025 number at $19.8 million, up 139.32% from a year prior.
  • Research & Development was $5.4 million for Q4 2025 at Amarin Corp Plc\Uk, up from $4.2 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $10.1 million in Q1 2022 to a low of -$7.4 million in Q4 2022.
  • A 5-year average of $4.2 million and a median of $5.5 million in 2024 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: plummeted 228.73% in 2022, then skyrocketed 253.76% in 2025.
  • Amarin Corp Plc\Uk's Research & Development stood at $5.8 million in 2021, then tumbled by 228.73% to -$7.4 million in 2022, then grew by 3.35% to -$7.2 million in 2023, then surged by 51.2% to -$3.5 million in 2024, then surged by 253.76% to $5.4 million in 2025.
  • Per Business Quant, the three most recent readings for AMRN's Research & Development are $5.4 million (Q4 2025), $4.2 million (Q3 2025), and $4.9 million (Q2 2025).